companies the-chemours-co 
Patently-O
FEBRUARY 24, 2022
by Dennis Crouch. The Supreme Court has not yet granted writ of certiorari in any patent cases this term. And, absent an unusual shadow-docket patent case, it is now too late for any case to be granted and heard this term. Rather, any new grant this term will very likely be pushed back to the October 2022 Term for hearing and decision. 35 U.S.C. ยง
Patently-O
JULY 22, 2021
The new Chemours Co. Chemours Company v. Chemours is a 2015 spin-off from Du Pont. Obviousness is the central doctrine of patent law. It is both the most common reason for rejection and often the most complicated issue because of both factual and legal complexities. Daikin Industries ( Fed. Patent Nos.
Fish & Richardson Trademark & Copyright Thoughts
FEBRUARY 7, 2022
10 YEARS AFTER THE AMERICA INVENTS ACT (AIA), THE PATENT TRIAL AND APPEAL BOARD (PTAB) ENDURES. After a heady 2020, 2021 proved to be a return to normalcy for the PTAB. While there was significant excitement early in the year about how the Supreme Court would rule in Arthrex , its decision in June mostly maintained the status quo. Arthrex, Inc.,
Expert insights. Personalized for you.
95 
Let's personalize your content